Drug Trial Radar · NCT02499562
A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis
Last checked: Nov 19, 2026Latest source record: Jun 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
168
Actual
Start
Jun 25, 2015
Primary completion
Nov 20, 2020
Study completion Nov 20, 2020
Sponsor
- Lead sponsor
- Shanghai Genomics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 16, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To explore the effective dose and safety of the effect of hydronidone and entecavir on hepatic fibrosis in chronic viral hepatitis B.
Conditions
- Hepatitis B, Chronic
Interventions
HydronidoneDrug
The investigational products in the test groups and control group shall be orally taken 30 minutes before meals for 52 continuous weeks. There are respectively 60 cases in the test group I, II, III and the control group, totally 240 cases.
PlaceboDrug
EntecavirDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in hepatic fibrosis in chronic viral hepatitis BTime frame: one year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Beijing, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.